Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 24,851–24,875 of 27,380 studies, newest first · page 995 of 1096.

May 2002 23

  1. 2002-05-01

    Hippocampal neurons in schizophrenia

    ✓ Peer-reviewed Hippocampus size on brain scans Journal of neural transmission (Vienna, Austria : 1996)

    Key finding: Neuropsychiatric disorders such as temporal lobe epilepsy, amnesia, and the dementias are associated with structural and functional abnormalities of specific hippocampal neurons. +2 more findings

  2. 2002-05-01

    Decision making in terminal care: a survey of finnish doctors' treatment decisions in end-of-life scenarios involving a terminal cancer and a terminal dementia patient

    ✓ Peer-reviewed End-of-life care Palliative medicine

    Key finding: Main results In the cancer case (Scenario 1) 17%, and in the dementia case (Scenario 2) 43% of all the respondents chose active treatment.

  3. 2002-05-01

    Assessing differences in care needs and service utilization in geriatric palliative care patients

    ✓ Peer-reviewed End-of-life care Journal of pain and symptom management

    Key finding: There were statistically significant differences across age groups in patient demographic and clinical characteristics, advance care planning, and service utilization.

  4. 2002-05-01

    Palliative and aggressive end-of-life care for patients with dementia

    ✓ Peer-reviewed End-of-life care Psychiatric services (Washington, D.C.)

    Key finding: Use of systemic antibiotics is prevalent in the treatment of patients with end-stage dementia, despite the limited utility and discomfort associated with the use of these agents. +2 more findings

  5. 2002-05-01

    Reduced mortality in treating acutely sick, frail older patients in a geriatric evaluation and management unit. A prospective randomized trial

    ✓ Peer-reviewed Clinical safety Journal of the American Geriatrics Society

    Key finding: Treatment of acutely sick, frail, older patients in a GEMU substantially reduced mortality. +1 more finding

  6. 2002-05-01

    An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients

    ✓ Peer-reviewed Clinical safety Psychosomatics

    Key finding: Several factors were found to be significantly associated with poorer response to olanzapine treatment for delirium, including age >70 years, history of dementia, central nervous system spread of cancer and hypoxia as delirium etiologies, "hypoactive" delirium, and delirium of "severe" intensity (i.e., MDAS >23). +1 more finding

  7. 2002-05-01

    Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study

    ✓ Peer-reviewed Clinical safety Annals of neurology

    Key finding: The presence of memory impairment was associated with more severe Alzheimer's disease pathology and higher incidence of conversion to dementia in the groups classified as having mild or global cognitive impairments. +2 more findings

  8. 2002-05-01

    Involvement of Maillard reactions in Alzheimer disease

    ✓ Peer-reviewed Disease mechanisms Neurotoxicity research

    Key finding: It is hoped that understanding of the mechanism of the AGEs formation and their role in the neurodegeneration will result in novel therapeutics for neuroprotection.

  9. 2002-05-01

    Coding Options for Central Auditory Processing

    ✓ Peer-reviewed Health systems and care delivery ASHA Leader

    Key finding: Scenario #1—Use of test battery code 92557 Comprehensive audiometry threshold $44.53 92567 Tympanometry $19.91 92568 Acoustic Reflex Testing $14.12 92569 Acoustic Reflex Decay Testing $15.20 92506 Evaluation of speech, language, voice, communication, and/or auditory processing $94.84 Total $188.60 CPT 92506, a code that represents a battery of tests, has a higher work value (i.e., higher reimbursement rate) associated with it than CPT codes for individual CAP tests (e.g., Staggered Spondaic Word test). +1 more finding

  10. 2002-05-01
  11. 2002-05-01

    Role of nitric oxide in inflammation-mediated neurodegeneration

    ✓ Peer-reviewed Inflammation and the immune system Annals of the New York Academy of Sciences

    Key finding: The hallmark of brain inflammation is the activation of glial cells, especially that of microglia that produce a variety of proinflammatory and neurotoxic factors, including cytokines, fatty acid metabolites, free radicals--such as nitric oxide (NO) and superoxide. +3 more findings

  12. 2002-05-01
  13. 2002-05-01

    Post-stroke depression, executive dysfunction and functional outcome

    ✓ Peer-reviewed Cognitive tests and assessment European journal of neurology

    Key finding: We sought to examine the correlates of executive dysfunction in a well-defined stroke cohort. +3 more findings

  14. 2002-05-01

    Antioxidant strategies for Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment The Proceedings of the Nutrition Society

    Key finding: In AD clinical trials molecules with antioxidant properties such as vitamin E and Ginkgo biloba extract have shown modest benefit. +4 more findings

  15. 2002-05-01

    Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila

    ✓ Peer-reviewed Lewy body dementia Neuron

    Key finding: Furthermore, manipulation of other wingless signaling molecules downstream from shaggy demonstrated that components of the Wnt signaling pathway modulate neurodegeneration induced by tau pathology in vivo but suggested that tau phosphorylation by GSK-3beta differs from canonical Wnt effects on beta-catenin stability and TCF activity.

  16. 2002-05-01

    Where does parkinson disease pathology begin in the brain?

    ✓ Peer-reviewed Lewy body dementia Journal of neuropathology and experimental neurology

    Key finding: Instead, the results of this semi-quantitative study of 30 autopsy cases with incidental Lewy body pathology indicate that PD in the brain commences with the formation of the very first immunoreactive Lewy neurites and Lewy bodies in non-catecholaminergic neurons of the dorsal glossopharyngeus-vagus complex, in projection neurons of the intermediate reticular zone, and in specific nerve cell types of the gain setting system (coeruleus-subcoeruleus complex, caudal raphe nuclei, gigantocellular reticular nucleus), olfactory bulb, olfactory tract, and/or anterior olfactory nucleus in the absence of nigral involvement.

  17. 2002-05-01

    Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neurobiology of aging

    Key finding: IMPase activity was relatively constant in CSF obtained from repeated lumbar puncture and there was no significant rostro-caudal gradient of activity in either normal or DS subjects, indicating that the enzyme originates from both brain and spinal cord. +3 more findings

  18. 2002-05-01

    Minority ethnic groups in dementia care: a review of service needs, service provision and models of good practice

    ✓ Peer-reviewed Disparities Aging & mental health

    Key finding: Although it has been argued that the instruments used to assess cognitive function are culturally biased, the available published evidence would seem to suggest that the fundamental issue is language ability, rather than minority group membership per se.

  19. 2002-05-01

    Measurement and correlates of family caregiver self-efficacy for managing dementia

    ✓ Peer-reviewed Caregiving Aging & mental health

    Key finding: Symptom management self-efficacy demonstrated a much stronger correlation with a published global caregiver competence measure than did service use self-efficacy (r = 0.49 and 0.27, respectively). +2 more findings

  20. 2002-05-01

    Assessing quality of life in older adults with cognitive impairment

    ✓ Peer-reviewed Caregiving Psychosomatic medicine

    Key finding: The QOL-AD seems to be reliable and valid for individuals with MMSE scores greater than 10.

  21. 2002-05-01

    Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Postmortem MRI scans were obtained for the first 56 participants of the Nun Study who were scanned.

  22. 2002-05-01

    Falls in cognitive impairment and dementia

    ✓ Peer-reviewed Prevention and risk Clinics in geriatric medicine

    Key finding: Older people with cognitive impairment and dementia are at increased risk for falls and subsequent adverse events. +1 more finding

  23. 2002-05-01

    Alzheimer disease and cerebrovascular pathology: an update

    ✓ Peer-reviewed Genetics Journal of neural transmission (Vienna, Austria : 1996)

    Key finding: Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82-98% often associated with ApoE epsilon 2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parietal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). +2 more findings

April 2002 2

  1. 2002-04-15

    Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

    ✓ Peer-reviewed Cognitive tests and assessment Principles and Practice of Geriatric Psychiatry

    Key finding: Accordingly, this program developed and evaluated clinical, neuropsychological and neuropathological assessments, an approach to neuroimaging, a standardized means of obtaining family history, and a behavior rating scale, as well as other measures. +4 more findings

  2. 2002-04-01

    Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness

    ✓ Peer-reviewed Tau biomarkers Frontiers in bioscience : a journal and virtual library

    Key finding: In the GTT2 study, assays of the CSF Abeta ratio ((Abeta40/ Abeta42(43)) showed a diagnostic sensitivity (59%) and specificity (88%) compared with non-AD type dementia and controls.

Browse the library by subject, with the full score breakdown →